So, Erdafitinib is this FGFR inhibitor thing. It’s mainly used for treating this kind of urothelial carcinoma that’s been spreading around with those FGFR2/3 changes. It stops that FGFR signaling deal, which is pretty big in how cancer keeps growing.
You’ve got Erdafitinib in these tablets that come in three strengths—3 mg, 4 mg, and 5 mg. They usually start with 8 mg a day, but if you need to, you can bump it up to 9 mg. Each bottle is packed with 56 tablets.
The main active stuff in Erdafitinib is good at shutting down the FGFR2/3 thing, which is a bit of a problem in some urothelial carcinomas. You should really get started on this under a doc’s watchful eye.
Reviews
There are no reviews yet.